Valuation: Synovics Pharmaceuticals, Inc.

Market Cap 1.64M 1.4M 1.31M 1.2M 2.26M 157M 2.3M 15.55M 6.06M 78.67M 6.16M 6.03M 260M P/E 2007
-0.73x
P/E 2008 -2.06x
Enterprise Value 8.13M 6.96M 6.49M 5.96M 11.2M 778M 11.42M 77.04M 30.03M 390M 30.52M 29.86M 1.29B EV / Sales 2007
1.81x
EV / Sales 2008 0.6x
Free-Float
95.75%
Yield 2007 *
-
Yield 2008 -
1 day+9,900.00%
3 months+9,900.00%
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0
10 years 0
Extreme 1.0E-6
0
Change 5-day change 1-year change 3-year change Capi.($)
+9,900.00%-.--%-.--%-.--% 3.65K
-2.81%+2.93%+76.40%+127.73% 1,141B
-2.21%+2.02%+49.50%+55.01% 659B
-1.56%+4.39%+25.19%+74.39% 470B
+1.20%+2.62%+41.69%+45.78% 366B
-0.61%+2.10%+23.43%+41.34% 302B
+0.32%+3.25%+0.94%+13.42% 254B
-1.95%+3.80%+46.31%+65.66% 239B
-1.10%-0.70%-14.31%-52.66% 207B
-2.82%+3.84%+20.81%+89.04% 183B
Average +988.85%+2.59%+27.00%+45.97% 382.1B
Weighted average by Cap. -1.64%+3.12%+43.48%+70.86%

Financials

2007 2008
Net sales 23.47M 20.09M 18.75M 17.2M 32.32M 2.25B 32.96M 222M 86.69M 1.13B 88.11M 86.19M 3.73B 25.96M 22.23M 20.74M 19.03M 35.76M 2.48B 36.46M 246M 95.9M 1.24B 97.47M 95.35M 4.12B
Net income -20.86M -17.86M -16.66M -15.29M -28.73M -2B -29.29M -198M -77.06M -1B -78.32M -76.61M -3.31B -4.01M -3.43M -3.2M -2.94M -5.52M -383M -5.63M -37.96M -14.8M -192M -15.04M -14.71M -636M
Net Debt 18.79M 16.09M 15.01M 13.77M 25.88M 1.8B 26.39M 178M 69.42M 901M 70.55M 69.02M 2.98B 6.49M 5.56M 5.18M 4.76M 8.94M 621M 9.11M 61.49M 23.97M 311M 24.36M 23.83M 1.03B
Logo Synovics Pharmaceuticals, Inc.
Synovics Pharmaceuticals, Inc. (Synovics) is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of generic over the counter (OTC) pharmaceutical products and generic prescription drug products. The Company is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The Company has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.
Employees
155
  1. Stock Market
  2. Stocks
  3. SYVC Stock